ZNF316
gene geneOn this page
Also known as MZF-3ENST00000305834
Summary
ZNF316 (zinc finger protein 316, HGNC:13843) is a protein-coding gene on chromosome 7p22.1, encoding Zinc finger protein 316 (A6NFI3). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 100131017 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 10 total
- MANE Select transcript:
NM_001278559
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13843 |
| Approved symbol | ZNF316 |
| Name | zinc finger protein 316 |
| Location | 7p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MZF-3, ENST00000305834 |
| Ensembl gene | ENSG00000205903 |
| Ensembl biotype | protein_coding |
| Entrez | 100131017 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 12 protein_coding, 1 retained_intron
ENST00000382252, ENST00000427912, ENST00000614588, ENST00000949893, ENST00000949894, ENST00000949895, ENST00000949896, ENST00000949897, ENST00000949898, ENST00000949899, ENST00000949900, ENST00000949901, ENST00000949902
RefSeq mRNA: 1 — MANE Select: NM_001278559
NM_001278559
CCDS: CCDS75563
Canonical transcript exons
ENST00000382252 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001491405 | 6652303 | 6658279 |
| ENSE00001594433 | 6641825 | 6641962 |
| ENSE00001637550 | 6639042 | 6639141 |
| ENSE00001665488 | 6642382 | 6642764 |
| ENSE00001753686 | 6637846 | 6638009 |
| ENSE00001774138 | 6637318 | 6637447 |
| ENSE00003558975 | 6643822 | 6643948 |
| ENSE00003624307 | 6642964 | 6643073 |
| ENSE00003684929 | 6644480 | 6644593 |
Expression profiles
Bgee: expression breadth ubiquitous, 221 present calls, max score 92.93.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.0125 / max 371.8702, expressed in 1803 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 77165 | 11.0017 | 1783 |
| 77166 | 2.9882 | 1320 |
| 77164 | 1.0226 | 709 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| kidney epithelium | UBERON:0004819 | 92.93 | silver quality |
| granulocyte | CL:0000094 | 92.82 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 90.98 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.15 | gold quality |
| sural nerve | UBERON:0015488 | 89.73 | gold quality |
| thyroid gland | UBERON:0002046 | 89.25 | gold quality |
| monocyte | CL:0000576 | 89.24 | gold quality |
| leukocyte | CL:0000738 | 89.05 | gold quality |
| body of uterus | UBERON:0009853 | 88.62 | gold quality |
| spleen | UBERON:0002106 | 88.58 | gold quality |
| vermiform appendix | UBERON:0001154 | 88.35 | gold quality |
| cortical plate | UBERON:0005343 | 88.26 | gold quality |
| stromal cell of endometrium | CL:0002255 | 87.87 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 87.81 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 87.80 | gold quality |
| mucosa of stomach | UBERON:0001199 | 87.75 | gold quality |
| caecum | UBERON:0001153 | 87.58 | gold quality |
| skin of leg | UBERON:0001511 | 87.53 | gold quality |
| right uterine tube | UBERON:0001302 | 87.37 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 87.36 | gold quality |
| lower esophagus | UBERON:0013473 | 87.35 | gold quality |
| apex of heart | UBERON:0002098 | 87.32 | gold quality |
| skin of abdomen | UBERON:0001416 | 87.13 | gold quality |
| left uterine tube | UBERON:0001303 | 87.10 | gold quality |
| right coronary artery | UBERON:0001625 | 87.01 | gold quality |
| body of stomach | UBERON:0001161 | 86.84 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 86.61 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 86.58 | gold quality |
| metanephros cortex | UBERON:0010533 | 86.56 | gold quality |
| fundus of stomach | UBERON:0001160 | 86.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.32 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
4 targets.
| Target | Regulation |
|---|---|
| PDLIM7 | |
| RGS2 | |
| S100A9 | |
| TRIM28 |
miRNA regulators (miRDB)
108 targeting ZNF316, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-6759-5P | 99.99 | 66.54 | 785 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp316 | ENSMUSG00000046658 |
| rattus_norvegicus | Zfp316 | ENSRNOG00000001094 |
Paralogs (1): ZNF787 (ENSG00000142409)
Protein
Protein identifiers
Zinc finger protein 316 — A6NFI3 (reviewed: A6NFI3)
All UniProt accessions (2): A0A087WZ61, A6NFI3
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_001265488* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (33 total): zinc finger region 15, compositionally biased region 6, modified residue 4, region of interest 3, cross-link 2, initiator methionine 1, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NFI3-F1 | 60.88 | 0.02 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (6): 2, 7, 10, 112, 829, 955
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 29 (showing top):
chr7p22, GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN, CHYLA_CBFA2T3_TARGETS_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, FOXN3_TARGET_GENES, TFEB_TARGET_GENES, MIR6778_3P, MIR4283, MIR6842_3P, MIR7855_5P, MIR212_5P, MIR4795_5P, MIR4772_5P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
768 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF316 | C2orf68 | Q2NKX9 | 480 |
| ZNF316 | HDDC2 | Q7Z4H3 | 462 |
| ZNF316 | PXDC1 | Q5TGL8 | 415 |
| ZNF316 | F5GXR3 | F5GXR3 | 374 |
| ZNF316 | METTL15 | A6NJ78 | 370 |
| ZNF316 | ASCL5 | Q7RTU5 | 370 |
| ZNF316 | ZNF512 | Q96ME7 | 356 |
| ZNF316 | IGHV3-11 | P01762 | 356 |
| ZNF316 | NDOR1 | Q9UHB4 | 354 |
| ZNF316 | KCNN2 | Q9H2S1 | 299 |
| ZNF316 | SLC25A31 | Q9H0C2 | 282 |
| ZNF316 | COPG2 | Q9UBF2 | 272 |
| ZNF316 | NEDD1 | Q8NHV4 | 257 |
| ZNF316 | GPATCH8 | Q9UKJ3 | 257 |
| ZNF316 | ABCA6 | Q8N139 | 256 |
IntAct
76 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF764 | ZNF316 | psi-mi:“MI:0914”(association) | 0.640 |
| ZNF764 | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF169 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF324B | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF707 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| VWCE | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| CACNG5 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| N | RBM47 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| RPS3 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| FBL | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ABT1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| NOTCH2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF316 | psi-mi:“MI:0914”(association) | 0.350 | |
| FBL | GXYLT2 | psi-mi:“MI:0914”(association) | 0.350 |
| EFEMP1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| N | RBM47 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (73): ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS)
ESM2 similar proteins: A0A2Z4LIS9, A2CE44, A6NFI3, E9PZZ1, O95201, P09066, P15863, P19622, P22091, P46099, P49640, P70338, P82976, P97503, P98168, P98169, Q05917, Q07120, Q13351, Q14549, Q14V87, Q15270, Q19A40, Q2QGD7, Q3SY56, Q3U133, Q58DK7, Q5DWN0, Q6IQX8, Q6NUN9, Q8C8V1, Q8NCA9, Q8TD94, Q8WUU4, Q924A2, Q92618, Q96RK0, Q99684, Q9BV97, Q9BYN7
Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 56 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Peptide chain elongation | 8 | 30.8× | 7e-09 |
| Viral mRNA Translation | 8 | 30.8× | 7e-09 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 8 | 30.4× | 7e-09 |
| Selenocysteine synthesis | 8 | 29.1× | 7e-09 |
| Eukaryotic Translation Termination | 8 | 29.1× | 7e-09 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 8 | 28.5× | 7e-09 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | 8 | 28.5× | 7e-09 |
| Formation of a pool of free 40S subunits | 8 | 27.1× | 9e-09 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cytoplasmic translation | 8 | 29.1× | 8e-08 |
| rRNA processing | 5 | 13.9× | 3e-03 |
| translation | 6 | 12.1× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
10 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1227 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:6642763:GG:G | donor_gain | 1.0000 |
| 7:6642764:GG:G | donor_gain | 1.0000 |
| 7:6642962:A:AG | acceptor_gain | 1.0000 |
| 7:6642962:AG:A | acceptor_gain | 1.0000 |
| 7:6642963:G:GA | acceptor_gain | 1.0000 |
| 7:6642963:GG:G | acceptor_gain | 1.0000 |
| 7:6642963:GGC:G | acceptor_gain | 1.0000 |
| 7:6642963:GGCC:G | acceptor_gain | 1.0000 |
| 7:6642963:GGCCT:G | acceptor_gain | 1.0000 |
| 7:6643068:TGTC:T | donor_gain | 1.0000 |
| 7:6643074:G:C | donor_loss | 1.0000 |
| 7:6643820:A:AG | acceptor_gain | 1.0000 |
| 7:6643820:AG:A | acceptor_gain | 1.0000 |
| 7:6643821:G:GT | acceptor_gain | 1.0000 |
| 7:6643821:GG:G | acceptor_gain | 1.0000 |
| 7:6643821:GGA:G | acceptor_gain | 1.0000 |
| 7:6643821:GGAGC:G | acceptor_gain | 1.0000 |
| 7:6643909:G:GT | donor_gain | 1.0000 |
| 7:6643909:G:T | donor_gain | 1.0000 |
| 7:6643921:G:GT | donor_gain | 1.0000 |
| 7:6643947:GG:G | donor_gain | 1.0000 |
| 7:6643948:GG:G | donor_gain | 1.0000 |
| 7:6643949:G:GG | donor_gain | 1.0000 |
| 7:6643949:GTA:G | donor_loss | 1.0000 |
| 7:6644474:T:A | acceptor_gain | 1.0000 |
| 7:6644475:GGCA:G | acceptor_loss | 1.0000 |
| 7:6644476:GCAG:G | acceptor_loss | 1.0000 |
| 7:6644478:A:AG | acceptor_gain | 1.0000 |
| 7:6644478:A:G | acceptor_loss | 1.0000 |
| 7:6644478:AG:A | acceptor_gain | 1.0000 |
AlphaMissense
6474 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:6652740:T:C | F382L | 1.000 |
| 7:6652742:C:A | F382L | 1.000 |
| 7:6652742:C:G | F382L | 1.000 |
| 7:6652803:T:C | C403R | 1.000 |
| 7:6652824:T:C | F410L | 1.000 |
| 7:6652825:T:C | F410S | 1.000 |
| 7:6652826:C:A | F410L | 1.000 |
| 7:6652826:C:G | F410L | 1.000 |
| 7:6653778:T:C | F728L | 1.000 |
| 7:6653780:C:A | F728L | 1.000 |
| 7:6653780:C:G | F728L | 1.000 |
| 7:6654030:T:C | F812L | 1.000 |
| 7:6654032:C:A | F812L | 1.000 |
| 7:6654032:C:G | F812L | 1.000 |
| 7:6654114:T:C | F840L | 1.000 |
| 7:6654116:C:A | F840L | 1.000 |
| 7:6654116:C:G | F840L | 1.000 |
| 7:6654198:T:C | F868L | 1.000 |
| 7:6654200:C:A | F868L | 1.000 |
| 7:6654200:C:G | F868L | 1.000 |
| 7:6654282:T:C | F896L | 1.000 |
| 7:6654283:T:C | F896S | 1.000 |
| 7:6654284:T:A | F896L | 1.000 |
| 7:6654284:T:G | F896L | 1.000 |
| 7:6654309:C:G | H905D | 1.000 |
| 7:6654366:T:C | F924L | 1.000 |
| 7:6654367:T:C | F924S | 1.000 |
| 7:6654368:C:A | F924L | 1.000 |
| 7:6654368:C:G | F924L | 1.000 |
| 7:6652741:T:C | F382S | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000187747 (7:6648682 CCAGA>C), RS1000220171 (7:6650299 C>G,T), RS1000267950 (7:6641460 G>C), RS1000344458 (7:6650509 G>A), RS1000519321 (7:6646289 G>T), RS1000635205 (7:6646533 C>T), RS1000780666 (7:6656556 A>G), RS1000860873 (7:6650688 A>T), RS1000868594 (7:6642622 G>A), RS1000913354 (7:6636370 C>A,T), RS1000944459 (7:6637222 C>A,G), RS1000966813 (7:6636587 C>G), RS1001104542 (7:6641437 C>A,G,T), RS1001195295 (7:6648076 T>C), RS1001320833 (7:6643624 TTTGAGC>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, increases expression, affects expression | 3 |
| Particulate Matter | increases abundance, increases expression | 2 |
| afuresertib | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| coumarin | affects phosphorylation | 1 |
| pentanal | increases expression | 1 |
| abrine | increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Quercetin | decreases phosphorylation | 1 |
| Smoke | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.